Understanding CAR-T Therapy in Multiple Myeloma: What Patients Need to Know image

Understanding CAR-T Therapy in Multiple Myeloma: What Patients Need to Know

May 20, 2026
01:00PM - 02:00PM EDT
Online Event
Overview
CAR-T therapy is changing how multiple myeloma is treated, but for many patients, it still feels confusing, overwhelming, or out of reach.
If you’ve ever wondered, “Is this something I should be considering?” or “What does this actually mean for me?” this session is for you.
 
Join Dr. Brandon Blue for a clear, patient-centered conversation that breaks down CAR-T therapy in a way that’s easy to understand. You’ll walk away with practical insight, answers to common questions, and more confidence in your next steps.
 
Participants will be asked to complete a brief survey before and after the session. It directly helps us understand what patients need to know and how we can better support real decision-making.
 
Register, complete the survey, and come ready with your questions.
 
If your HealthTree profile is not fully completed beyond registration, you will be asked to provide a few additional details before accessing the survey. This may include basic demographic information and information about your care, such as where you are being treated.
 
COMPLETE SURVEY
 
 
Agenda
1:00 PM
Introductions
Valarie Traynham

Valarie introduces the agenda of the event and our featured speaker Dr. Brandon Blue

1:05 PM
Presentation
Brandon Blue, MD

Dr. Cook talks about bispecific therapy for myeloma

1:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators
Healthtree contact Valarie Traynham

Valarie Traynham

Valarie embarked on her myeloma journey back in 2015, and ever since she's been on a mission. As a resilient myeloma thriver, her passion lies in not just navigating her own path but also in illuminating the journey for others. With a steadfast commitment to understanding the intricacies of the disease, she champions education, shedding light on health inequities that often lurk in the shadows. Driven by a profound belief in fairness, Valarie tirelessly advocates for equitable access to top-tier healthcare, clinical trials, and tailored treatments. Her journey as a beacon of knowledge and support began when she assumed the role of a support group leader. Today, she continues to extend her hand as a myeloma coach, mentor angel, and the guiding force behind the Black Myeloma Health Community. Valarie's voice echoes far and wide as she fearlessly confronts the disparities faced by myeloma patients. Through collaborative efforts with healthcare providers, she strives to forge pathways to solutions, ensuring that every individual receives the care they deserve. Join Valarie on her journey of empowerment and advocacy as she lights the way toward a brighter, more equitable future in myeloma care.
Healthtree contact Brandon Blue, MD

Brandon Blue, MD

Brandon Blue, MD Assistant Member, Malignant Hematology Department H. Lee Moffitt Cancer Center & Research Institute Dr. Blue is an Assistant Member and Clinical Instructor in the Department of Malignant Hematology at Moffitt Cancer Center. He earned his MD from Meharry Medical College in Nashville, TN. He completed an Internal Medicine Residency in the Department of Medicine at Washington University School of Medicine and a Hematology/Oncology Fellowship at St. Louis University School of Medicine in St. Louis, Missouri. Dr. Blue completed a Blood and Marrow Transplant and Cellular Immunotherapy Fellowship at Moffitt Cancer Center. Dr. Blue’s clinical interests include treatment of plasma cell disorders and evaluation of patients pre and post stem cell and bone marrow transplant. His research interests include reducing health disparities and improving health outcomes for plasma cell dyscrasias.